These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28339500)

  • 1. Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana.
    Ajibola G; Zash R; Shapiro RL; Batlang O; Botebele K; Bennett K; Chilisa F; Widenfelt EV; Makhema J; Lockman S; Holmes LB; Powis KM
    PLoS One; 2017; 12(3):e0173800. PubMed ID: 28339500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
    PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
    Veroniki AA; Antony J; Straus SE; Ashoor HM; Finkelstein Y; Khan PA; Ghassemi M; Blondal E; Ivory JD; Hutton B; Gough K; Hemmelgarn BR; Lillie E; Vafaei A; Tricco AC
    PLoS One; 2018; 13(6):e0198447. PubMed ID: 29912896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine use in pregnancy and congenital malformations.
    Rough K; Sun JW; Seage GR; Williams PL; Huybrechts KF; Bateman BT; Hernandez-Diaz S
    AIDS; 2017 Jul; 31(12):1733-1743. PubMed ID: 28537936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
    Bae WH; Wester C; Smeaton LM; Shapiro RL; Lockman S; Onyait K; Thior I; Essex M
    AIDS; 2008 Aug; 22(13):1633-40. PubMed ID: 18670224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.
    Lockman S; Hughes M; Powis K; Ajibola G; Bennett K; Moyo S; van Widenfelt E; Leidner J; McIntosh K; Mazhani L; Makhema J; Essex M; Shapiro R
    Lancet Glob Health; 2017 May; 5(5):e491-e500. PubMed ID: 28395844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth outcomes following zidovudine exposure in pregnant women: the Antiretroviral Pregnancy Registry.
    White A; Eldridge R; Andrews E
    Acta Paediatr Suppl; 1997 Jun; 421():86-8. PubMed ID: 9240865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.
    Lambert JS; Watts DH; Mofenson L; Stiehm ER; Harris DR; Bethel J; Whitehouse J; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H; van Dyke R; Maupin R; Silio M; Fowler MG
    AIDS; 2000 Jul; 14(10):1389-99. PubMed ID: 10930154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana.
    Bussmann H; Wester CW; Wester CN; Lekoko B; Okezie O; Thomas AM; DeGruttola SM; Makhema J; Essex M; Marlink RG
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):269-73. PubMed ID: 17450102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral Therapy.
    Zash RM; Souda S; Leidner J; Binda K; Hick C; Powis K; Makhema J; Mmalane M; Essex M; Lockman S; Shapiro RL
    AIDS Patient Care STDS; 2017 Jan; 31(1):14-19. PubMed ID: 28051898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.
    Chen JY; Ribaudo HJ; Souda S; Parekh N; Ogwu A; Lockman S; Powis K; Dryden-Peterson S; Creek T; Jimbo W; Madidimalo T; Makhema J; Essex M; Shapiro RL
    J Infect Dis; 2012 Dec; 206(11):1695-705. PubMed ID: 23066160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.